RedHill Biopharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Aug 31, 2017 11:00 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 31, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...
Assembly Biosciences Announces September Conference Participation
Aug 31, 2017 11:00 am UTC| Business
INDIANAPOLIS, Aug. 31, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
EnviroLeach Announces Partnership with Jabil for E-Waste Processing
Aug 31, 2017 11:00 am UTC| Business
VANCOUVER, British Columbia, Aug. 31, 2017 -- EnviroLeach Technologies Inc. (CSE:ETI) (OTCQB:EVLLF), is pleased to announce that it has entered into a strategic global partnership with Jabil Inc. (NYSE:JBL). As part of...
Apricus Biosciences Announces FDA Acknowledgement of Vitaros™ Class 2 NDA Resubmission
Aug 31, 2017 11:00 am UTC| Business
SAN DIEGO, Aug. 31, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug Administration...
Mersana Therapeutics to Participate in Investor Conferences in September
Aug 31, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Aug. 31, 2017 -- Mersana Therapeutics, Inc. (NASDAQ:MRSN) today announced that Anna Protopapas, President and Chief Executive Officer, will participate in three upcoming investor conferences in...
Aug 31, 2017 11:00 am UTC| Business
OXFORD, United Kingdom, Aug. 31, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile...
Aug 31, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 31, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...